October | 2023 | Internet | Biotech Stock Review | Page 3

Home 2023 October

Marijuana Stock Review

Vext (VEXTF) Announces Closing of $11.5 Million Private Placement.

Editor / Curator - October 12, 2023

Biotech News

Tempest Therapeutics’ (TPST) Stock Jumps 1,980%. $0.25 to $5.20

Editor / Curator - October 11, 2023

2024 Watch List

Adding GeoVax (GOVX) $0.52 to Watch List.

Editor / Curator - October 11, 2023

All News

Society Pass (SOPA) Plans to Spinout of Two Units Into New...

Editor / Curator - October 10, 2023

All News

Dawson James Securities 8th Annual Small Cap Growth Conference.

Editor / Curator - October 10, 2023

2021 Watch List

Ouch…Omniq (OMQS).

Editor / Curator - October 9, 2023

All News

Greatest Interview with Arthur Hayes.

Editor / Curator - October 9, 2023

All News

Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction

Editor / Curator - October 9, 2023

2023 Watch List

Is Ardelyx (ARDX) $4.00 Ready to Break Out?

Editor / Curator - October 2, 2023

All News

The Resurgence Of Selling Shareholders In Microcap IPOs

Editor / Curator - October 2, 2023

1 234 Page 3 of 4

Latest article

Jeffrey Gundlach: Reckoning is Coming.

All News Editor / Curator - June 14, 2025

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

All News Editor / Curator - June 12, 2025

Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

All News Editor / Curator - June 12, 2025

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...

The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062